Jun Activators consist of a diverse array of chemical compounds that enhance the functional activity of the Jun protein through various intracellular signaling pathways. Anisomycin functions by activating JNK, which phosphorylates Jun, thus enhancing its transcriptional activity, which is crucial for cell proliferation and differentiation. Similarly, TPA works by activating PKC, leading to subsequent phosphorylation and activation of Jun, exemplifying the intricate signaling networks that regulate Jun's role in gene expression. The role of Forskolin is to increase cAMP levels, which in turn activate PKA; this kinase can phosphorylate Jun, thus enhancing its transcriptional control mechanisms. EGF stimulates its receptor, leading to downstream MAPK/ERK pathway signaling, culminating in Jun activation, which showcases the protein's responsiveness to growth factors.
Furthermore, the application of PD 98059 results in MEK inhibition, which could initiate compensatory feedback mechanisms that enhance Jun activity, indicating the complexity of cellular signaling cascades and their impact on transcription factors like Jun. SP600125, while typically a JNK inhibitor, may reduce negative feedback on AP-1, of which Jun is a part, thereby potentially enhancing its activity. The inhibition of p38 MAPK by SB203580 may relieve repression on Jun, leading to increased activity. Curcumin's modulation of various signaling pathways can indirectly lead to Jun activation due to cellular compensatory responses. Resveratrol's activation of SIRT1 leads to the deacetylation of Jun, influencing its transcriptional activity. Zinc sulfate provides structural support to the AP-1 complex enhancing Jun activity, while LY294002's inhibition of PI3K can affect Jun activity through feedback regulation. Lastly, U0126's inhibition of MEK1/2 can lead to the activation of alternative pathways that upregulate Jun activity, underlining the adaptive nature of cellular signaling processes in response to external stimuli and inhibitors.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
TPA activates protein kinase C (PKC) which can phosphorylate Jun, leading to its enhanced transcriptional activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels, activating PKA. PKA can then phosphorylate Jun, resulting in increased activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 indirectly enhances Jun activity by inhibiting MEK, which may lead to compensatory feedback mechanisms that upregulate Jun activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which can alleviate p38 MAPK-mediated repression on Jun, thereby enhancing its activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1 which can deacetylate Jun, affecting its activity state positively. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc acts as a cofactor for many transcription factors and may enhance Jun activity by stabilizing the AP-1 complex structure. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which can modulate AKT activity and potentially enhance Jun activity through noncanonical feedback regulation. | ||||||